Researchers pinpoint pre-diagnosis care paths in people with Alzheimer’s disease, other dementia
By
Kristen Fischer
Jan 26, 2024
Every person with Alzheimer’s disease and related dementias has a unique journey of how they discovered their diagnosis. A new study in Alzheimer’s & Dementia examined the patterns that led up...
Blood test accurate, consistent at spotting Alzheimer’s, dementia-linked proteins
By
Kristen Fischer
Jan 24, 2024
A new blood test that can spot amyloid and tau in the brain should be on the market soon. The test worked well to accurately and consistently identify accumulations of the proteins implicated in Alzheimer’s...
Quest launches consumer test for Alzheimer’s
By
Kristen Fischer
Aug 01, 2023
People can buy a blood test to check their levels of beta amyloid — a protein that’s known to contribute to Alzheimer’s disease. They can go directly to a Quest lab for bloodwork; the company’s...
Survey: U.S. neurologists would prescribe Leqembi if fully approved
By
Alicia Lasek
Apr 12, 2023
A “healthy proportion” of surveyed neurologists have already begun prescribing the treatment, and nearly all said they planned to do so if traditional FDA approval is granted.
Alzheimer’s blood biomarkers not ready for primary care use, expert panel decides
By
Alicia Lasek
Aug 18, 2022
An international group of clinicians and researchers have agreed that Alzheimer’s disease blood biomarkers are a significant breakthrough, but are not yet ready for general clinical and primary care...
Managing Alzheimer’s as chronic disease will require clinician, patient education, docs say
May 03, 2022
Most primary care physicians foresee a time when dementia is managed as a chronic disease, new surveys from Quest Diagnostics have found.
U.S. lawmakers ramp up scrutiny of FDA following agency’s approval of controversial Alzheimer’s drug
By
Alicia Lasek
Sep 07, 2021
The FDA is being asked to help explain how Aduhelm (aducanumab) met accelerated approval criteria when so many experts — including internal advisers — have flagged insufficient safety and efficacy...
Low-dose brain radiation improves behavior, cognition in Alzheimer’s pilot study
By
Alicia Lasek
May 04, 2021
Low-dose ionizing radiation may be a promising, although possibly controversial, therapy for Alzheimer’s disease, according to the researchers behind a small new pilot study.
Alzheimer’s cure would mean $16B in lost revenues for assisted living
By
Lois A. Bowers
Sep 17, 2019
A cure for Alzheimer’s disease would be a “medical miracle” but would result in a loss of $16.3 billion in assisted living annual revenues.